RxDoctor Payments Data

Susan Johnson, MD

Obstetrics & Gynecology · Laguna Hills, CANPI 1568572535

Payments from drug & device makers

$954in general payments, 2019–2025

Across 40 payments — averaging $23.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$287
  • AbbVie$169
  • Therapeuticsmd, Inc.$56
  • Bayer$46
  • Hologic Sales And Service, LLC$46
  • Coopersurgical, Inc.$45
  • plus $304 from 14 others

What the payments were for

  • Food & beverage$954100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$954 in reported general payments places this provider in the 60th percentile of 3,784 obstetrics & gynecology providers in California.

See all obstetrics & gynecology providers in California

Medicare billing

Part B allowed, 2024
$55,725
Medicare patients
262
Services billed
861

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol222$19,622
PremarinEstrogens, Conjugated13$6,012
PremproEstrogen,con/M-Progest Acet13$4,845
YuvafemEstradiol28$4,719
ImvexxyEstradiol14$4,006
Estradiol (Twice Weekly)Estradiol24$2,645
ProgesteroneProgesterone, Micronized38$1,390
ValacyclovirValacyclovir Hcl16$1,211
Ibandronate Sodium21$1,007
Alendronate Sodium37$370
Clobetasol Propionate12$232
Escitalopram Oxalate13$130
Medroxyprogesterone Acetate11$103

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin, Prempro$31$10,85726 claims
Therapeuticsmd, Inc.Imvexxy$56$4,00614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,784 obstetrics & gynecology providers in California.

Other obstetrics & gynecology in Laguna Hills

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →